Hologic Announces Financial Results for Third Quarter of Fiscal 2018

Go back to Hologic Announces Financial Results for Third Quarter of Fiscal 2018

Hologic (HOLX) PT Raised to $48 at Needham & Company

August 1, 2018 7:55 AM EDT

Needham & Company raised its price target on Hologic (NASDAQ: HOLX) to $48.00 (from $43.00) while maintaining a Buy rating.

Analyst Mike Matson commented, "HOLX's F3Q18 revenue and EPS beat consensus. Management raised its FY18 revenue guidance and narrowed its EPS guidance range.... More

Hologic (HOLX) PT Raised to $45 at Cowen

August 1, 2018 7:26 AM EDT

Cowen raised its price target on Hologic (NASDAQ: HOLX) to $45.00 (from $44.00) while maintaining an Outperform rating.

Analyst Doug Schenkel commented, "Hologic beat FQ3 revenue and EPS expectations even adjusted for favorable non-core items. While there are numerous moving parts, updated full year... More

Hologic (HOLX) PT Raised to $46 at Evercore ISI

August 1, 2018 7:17 AM EDT

Evercore ISI raised its price target on Hologic (NASDAQ: HOLX) to $46.00 (from $43.00) while maintaining a Outperform rating.

What analyst Vijay Kumar liked in the quarter:

Overall organic revenue beat was driven by outperformanceFull year guidance organic growth was raised by... More

Hologic (HOLX) Tops Q3 EPS by 2c

July 31, 2018 4:04 PM EDT

Hologic (NASDAQ: HOLX) reported Q3 EPS of $0.58, $0.02 better than the analyst estimate of $0.56. Revenue for the quarter came in at $824 million versus the consensus estimate of $800.44... More